TERT promoter mutations and polymorphisms as prognostic factors in primary glioblastoma.
Mosrati MA, Malmström A, Lysiak M, Krysztofiak A, Hallbeck M, Milos P, Hallbeck AL, Bratthäll C, Strandéus M, Stenmark-Askmalm M, Söderkvist P.
Mosrati MA, et al. Among authors: hallbeck m, hallbeck al.
Oncotarget. 2015 Jun 30;6(18):16663-73. doi: 10.18632/oncotarget.4389.
Oncotarget. 2015.
PMID: 26143636
Free PMC article.